In another note of news, a key aide to HHS Secretary Robert F. Kennedy Jr. said that popular GLP-1 weight loss drugs -- Novo Nordisk's ( NVO) Wegovy (semaglutide) and Eli Lilly's ( LLY) Zepbound ...

As tech giants inch toward self-sufficiency, Nvidia’s ( NVDA) investment in sovereign AI projects and alternative cloud ...

The current U.S. housing slowdown is the fastest Federal Reserve-driven slowdown in history, according to Apollo Global ...

Extending its six-week rebound to over 15%, the S&P 500 surged 5.3% - closing within 3% of its all-time record high. REITs lagged, however, as interest rates breached three-month highs.

JEPI remains a reliable income-focused ETF, consistently delivering its 8% annual payout target since inception despite ...

Virgin Galactic's recent stock surge is likely a short squeeze, not a sign of renewed fundamental strength or a secure future ...

JEPI has amassed $39.63 billion in assets under management since its inception in 2020, establishing itself as a leading high ...

The S&P 500's 1.3% yield and volatility don’t suit most retirees. See why our balanced portfolio targets 5–6% income with ...

TC Energy offers stable income through fee-based revenues, strong gas assets, and a 4.9% yield, but trades above historical ...

HEPZATO launch shows strong revenue growth, profitability, and U.S. expansion, marking a biotech turning point. Read why DCTH stock is a buy.

MakeMyTrip delivered strong 4Q25 results, driven by 30%+ bookings growth, AI innovation, and expanding international revenue.

Alibaba’s AI-driven cloud growth, open-source leadership, and strong user momentum support long-term upside. Learn why BABA ...